Abstract
Background
Study design
Results
Conclusions
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to ContraceptionReferences
- Maternal morbidity and mortality associated with interpregnancy interval: cross sectional study.BMJ. 2000; 321: 1255-1259
- Contraception and health.Lancet. 2012; 380: 149-156
- The Millennium Development Goals report. New York: United Nations; 2010.([cited 2011 March 3, 2011]; Available from:)
- Family planning handbook: a global handbook for providers. Baltimore and Geneva: Department of Reproductive Health and Research Johns Hopkins Bloomberg School of Public Health Center for Communication Programs INFO Project; 2011.([cited 2012 January 30]; Available from:)
- World Health Organization medical eligibility criteria for contraceptive use. 3rd ed. WHO, Geneva2004 ([cited 2010]; Available from:)
- World contraceptive use 2011. United Nations.([8 November 2012]; Available from:)
- International Contraceptive Access (ICA) Foundation home page. International Contraceptive Access (ICA) Foundation.(Available from:)
- Levonorgestrel-releasing intrauterine system for heavy menstrual bleeding improves hemoglobin and ferritin levels.Contraception. 2012; 86: 452-457
Medicines360. Available from: http://www.medicines360.org/.
- A study of a levonorgestrel-releasing intrauterine system for long-term, reversible contraception. Clintrials.gov..(Available from:)
Hormonal IUD. Uteron Pharma; Available from: http://www.odyssea-pharma.be/Hormonal-IUD.html?lang=en.
- Interventions for pain with intrauterine device insertion.Cochrane Database Syst Rev. 2009; ([Review]): CD007373
- Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons.Contraception. 2009; 80: 113-118
- Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study.Contraception. 1990; 42: 361-378
- Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial.Contraception. 1994; 49: 56-72
Article info
Publication history
Footnotes
���Funding for this project was provided to FHI 360 by the US Agency for International Development [GPO-A-00-08-00001-00, Program Research for Strengthening Services (PROGRESS)]. The views expressed in this publication do not necessarily reflect those of FHI 360, the ICA Foundation or USAID.